Aprotinin and major orthopedic surgery

European Spine Journal

Volumn 13, Issue SUPPL. 1, 2004, Pages

  Samama, Charles Marc ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Aprotinin; Bleeding; Orthopaedic surgery; Thrombosis; Transfusion

Indexed keywords

APROTININ; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ANAPHYLAXIS; BLEEDING; BLOOD TRANSFUSION; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HEMOSTASIS; HUMAN; IDIOPATHIC SCOLIOSIS; LUNG EMBOLISM; MAJOR SURGERY; MEDICAL DECISION MAKING; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SPINE FUSION; SPINE SURGERY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

APROTININ; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; HEMOSTATICS; HUMANS; ORTHOPEDIC PROCEDURES; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SPINAL FUSION; THROMBOSIS; TREATMENT OUTCOME;

EID: 8444236780     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-004-0744-y     Document Type: Review

References (30)

1. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A (1998) Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116:716-730
2. Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey JA (2003) Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 98: 337-342
3. Capdevila X, Calvet Y, Biboulet P, Biron C, Rubenovitch J, D'Athis F (1998) Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 88:50-57
4. Cosgrove D 3rd, Heric B, Lytle B, Taylor P, Novoa R, Golding L, Stewart L, McCarthy P, Loop FD (1992) Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 54: 1031-1038
5. Dewachter P, Mouton C, Massen C, Gueant JL, Haberer JP (1993) Anaphylactic reaction to aprotinin during cardiac surgery [letter]. Anaesthesia 48: 1110-1111
6. Diefenbach C, Abel M, Limpers B, Lynch J, Ruskowski H, Jugert FK, Buzello W (1995) Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. Anesth Analg 80:830-831
7. Dietrich W (1998) Incidence of hypersensitivity reactions. Ann Thorac Surg 65 [Suppl]:S60-S74
8. Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92:775-780
9. Espana F, Estelles A, Griffin J, Aznar J, Gilabert J (1989) Aprotinin (Trasylol) is a competitive inhibitor of activated protein C. Thromb Res 56:751-756
10. Fitzsimons MG, Peterfreund RA, Raines DE (2001) Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. Anesth Analg 92:1418-1421
11. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119: 132S-175S
12. Godet G, Bertrand M, Samama CM, Barré E, Fléron MH, Baron JF, Coriat P, Kieffer E, Viars P (1994) Aprotinin decreases blood loss and blood transfusion requirements in thoracic and thoraco-abdominal aortic surgery under extra-corporeal circulation. Ann Vasc Surg 8:452-456
13. Hayes A, Murphy DB, McCarroll M (1996) The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth 8:357-360
14. Janssens M, Joris J, David JL, Lemaire R, Lamy M (1994) High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 80:23-29
15. Jeserschek R, Clar H, Aigner C, Rehak P, Primus B, Windhager R (2003) Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery. A prospective, double blind, randomized and placebo-controlled study. J Bone Joint Surg Br 85B: 174-177
16. Kasper SM, Eisner F, Hilgers D, Grond S, Rutt J (1998) A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty. Eur J Anaesthesiol 15:669-675
17. Khoshhal K, Mukhtar I, Clark P, Jarvis J, Letts M, Splinter W (2003) Efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Pediatr Orthop 23:661-664
18. Kovesi T, Royston D (2003) Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang 84: 2-10
19. Langdown AJ, Field J, Grote J, Himayat H (2000) Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. J Arthroplasty 15: 1009-1012
20. Lentschener C, Cottin P, Bouaziz H, Mercier FJ, Wolf M, Aljabi Y, Boyer-Neumann C, Benhamou D (1999) Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 89: 590-597
21. Levy JH, Bailey JM, Salmenpera M (1994) Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology 80:1013-1018
22. Murkin JM, Shannon NA, Bourne RB, Rorabeck CH, Cruickshank M, Wyile G (1995) Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg 80:343-348
23. Murkin JM, Haig GM, Beer KJ, Cicutti N, McCutchen J, Comunale ME, Hall R, Ruzicka BB (2000) Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 82: 675-684
24. Porte RJ, Leebeek FWG (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62:2193-2211
25. Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, Palareti G, Hermans J, Terpstra OT, for the EMSALT Study Group (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet 355: 1303-1309
26. Royston D, Bistrup BP, Taylor KM, Sapsford RN (1987) Effects of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2:1289-1291
27. Samama CM, Dietrich W, Horrow J, Taby O, Samama MM (2000) Structure, pharmacology, and clinical use of antifibrinolytic agents. In: Bachman F (ed) Handbook of experimental pharmacology, fibrinolytics and antifibrinolytics. Springer, Berlin Heidelberg New York, pp 559-585
28. Samama CM, Langeren O, Rosencher N, Capdevila N, Rouche P, Pegoix M, Bernière J, Coriat P, for the HACOL Study Group (2002) Aprotinin versus placebo in major orthopedic surgery: a randomized double-blinded dose-ranging study. Anesth Analg 95:287-293
29. Thorpe CM, Murphy WG, Logan M (1994) Use of aprotinin in knee-replacement surgery. Br J Anaesth 73: 408-410
30. Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O (2001) The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive surgery. Spine 26: 1152-1157